CA
NZ
UK
AU
IND
US
…
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Bio Green Med Solution, Inc. (NASDAQ: BGMS) is a publicly listed company, but readily available filings and corporate disclosures provide limited detail on its core operations and product portfolio. Because long-term growth drivers are not well documented, investors should monitor future filings for verifiable revenue streams, regulatory milestones, or clear commercialization plans that could support valuation.
Primary investment risks include limited transparency and financial disclosure, minimal operating history or revenues, low liquidity and high share‑price volatility, and material regulatory or execution uncertainty.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -2.99M | -11.99M | -25.55M | -25.91M | -22.18M |
| Net income | -3.00M | -11.21M | -22.55M | -21.20M | -18.46M |
| Selling general administrative | 7.72M | 5.39M | 6.72M | 7.38M | 7.46M |
| Gross profit | 0.14M | 0.04M | 0.42M | -0.03M | -0.04M |
| Reconciled depreciation | 0.01M | 0.01M | 0.03M | 0.03M | 0.04M |
| Ebit | -8.43M | -12.00M | -25.45M | -27.66M | -22.39M |
| Ebitda | -8.42M | -12.00M | -25.42M | -27.62M | -22.35M |
| Depreciation and amortization | 0.01M | 0.01M | 0.03M | 0.03M | 0.04M |
| Operating income | -8.43M | -12.00M | -25.45M | -27.66M | -22.39M |
| Other operating expenses | 9.17M | 12.05M | 25.87M | 27.66M | 22.39M |
| Tax provision | 0.01M | -0.78M | -3.00M | -4.72M | -3.73M |
| Interest income | 0.06M | 0.01M | 0.27M | 0.21M | 0.02M |
| Net interest income | 0.06M | 0.01M | 0.27M | 0.21M | 0.02M |
| Income tax expense | 0.01M | -0.78M | -3.00M | -4.72M | -3.73M |
| Total revenue | 0.75M | 0.04M | 0.42M | 0.00M | 0.00M |
| Total operating expenses | 8.56M | 12.05M | 25.87M | 27.66M | 22.39M |
| Cost of revenue | 0.61M | 0.00M | - | 0.03M | 0.04M |
| Total other income expense net | 5.44M | 0.01M | -0.10M | 1.74M | 0.20M |
| Net income from continuing ops | -3.00M | -11.21M | -22.55M | -21.20M | -18.46M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 8.19M | 4.09M | 8.80M | 28.05M | 43.14M |
| Other current assets | 0.11M | 0.30M | 0.34M | 0.43M | 0.08M |
| Total liab | 1.34M | 6.27M | 8.20M | 7.62M | 5.44M |
| Total stockholder equity | 6.84M | -2.17M | 0.61M | 20.43M | 37.69M |
| Other current liab | 0.71M | 1.67M | 4.62M | 4.95M | 3.30M |
| Common stock | 0.01M | 0.01M | 0.00M | 4.50M | 0.01M |
| Capital stock | 0.01M | 0.01M | 0.00M | 4.50M | 0.01M |
| Retained earnings | -454.41M | -439.49M | -428.28M | -405.73M | -384.53M |
| Good will | 1.57M | 0.00M | - | - | - |
| Other assets | - | 0.00M | - | - | - |
| Cash | 3.50M | 3.14M | 3.38M | 18.34M | 36.56M |
| Total current liabilities | 1.33M | 6.27M | 8.16M | 7.51M | 5.41M |
| Net debt | -3.50M | -3.14M | -3.34M | -18.24M | -36.53M |
| Short long term debt total | 0.00M | - | 0.04M | 0.11M | 0.03M |
| Other stockholder equity | 461.29M | 438.20M | 429.80M | 422.98M | 422.96M |
| Total current assets | 6.26M | 3.67M | 7.44M | 24.41M | 40.94M |
| Net receivables | 1.26M | 0.24M | 3.73M | 5.64M | 4.30M |
| Inventory | 1.38M | 0.00M | - | - | - |
| Accounts payable | 0.62M | 4.60M | 3.54M | 2.56M | 2.12M |
| Accumulated other comprehensive income | -0.04M | -0.89M | -0.91M | -1.32M | -0.75M |
| Non currrent assets other | 0.21M | 0.41M | 1.26M | 3.46M | 2.10M |
| Non current assets total | 1.93M | 0.42M | 1.36M | 3.64M | 2.19M |
| Capital lease obligations | 0.00M | 0.00M | 0.04M | 0.11M | 0.03M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | 0.00M | -0.01M | -0.01M | -0.03M |
| Total cashflows from investing activities | - | - | -0.01M | -0.01M | -0.03M |
| Total cash from financing activities | 5.26M | 7.82M | 0.85M | 3.00M | 21.74M |
| Net income | -3.00M | -11.21M | -22.55M | -21.20M | -18.46M |
| Change in cash | 0.37M | -0.24M | -14.97M | -18.21M | 3.15M |
| Begin period cash flow | 3.14M | 3.38M | 18.34M | 36.56M | 33.41M |
| End period cash flow | 3.50M | 3.14M | 3.38M | 18.34M | 36.56M |
| Total cash from operating activities | -4.77M | -7.99M | -16.11M | -20.83M | -18.54M |
| Issuance of capital stock | 6.42M | 6.21M | 1.05M | 3.20M | 17.37M |
| Depreciation | 0.01M | 0.01M | 0.03M | 0.03M | 0.04M |
| Dividends paid | 0.06M | 0.00M | 0.20M | 0.20M | 0.20M |
| Change to inventory | -1.38M | 0.00M | - | - | - |
| Change to account receivables | -1.26M | 0.00M | - | - | - |
| Other cashflows from financing activities | -1.10M | 1.61M | - | - | 4.57M |
| Capital expenditures | 0.00M | 0.00M | 0.01M | 0.01M | 0.03M |
| Change in working capital | -9.06M | 2.62M | 4.94M | -1.17M | -1.28M |
| Stock based compensation | 2.33M | 0.59M | 1.47M | 1.51M | 1.16M |
| Other non cash items | 4.95M | -0.04M | -0.07M | - | - |
| Free cash flow | -4.77M | -7.99M | -16.12M | -20.83M | -18.57M |
Sector: Healthcare Industry: Biotechnology
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BGMS Bio Green Med Solution, Inc. |
0.04 5.94% |
0.71 | - | - | 8.76 | 0.96 | 4.07 | 0.02 |
| NVO Novo Nordisk A/S |
-0.54 1.32% |
40.55 | 41.58 | 31.15 | 2.13 | 32.99 | 2.11 | 4.70 |
| VRTX Vertex Pharmaceuticals Inc |
-2.37 0.43% |
544.66 | 30.22 | 24.27 | 10.36 | 6.50 | 9.99 | 24.66 |
| REGN Regeneron Pharmaceuticals Inc |
-2.77 0.29% |
956.64 | 29.07 | 20.12 | 7.57 | 3.82 | 6.95 | 19.42 |
| ARGNF argenx SE |
- -% |
900.30 | 45.77 | 31.25 | 13.84 | 7.12 | 11.38 | 36.06 |
Bio Green Med Solution, Inc. engages in the distributing, trading, and installation of protective and fire safety materials and equipment, and fire protection and prevention systems. It also researches and develops pharmaceuticals. The company was formerly known as Cyclacel Pharmaceuticals, Inc. and changed its name to Bio Green Med Solution, Inc. in September 2022. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.
| Name | Title | Year Born |
|---|---|---|
| Dr. Sing Ee Wong | Chairman, CEO & President | 1981 |
| Mr. Cu Seng Kiu | Executive Director, CFO & Secretary | 1990 |
| Ms. Gill Christie | Director of Human Resources | 1957 |
| Grace Kim | Investor Relations Executive | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.40%
Communication Services
-0.45%
Consumer Cyclical
-0.55%
Consumer Defensive
-0.01%
Energy
-0.01%
Financial Services
-0.40%
Financials
-0.15%
Healthcare
-1.15%
Industrials
-0.46%
Real Estate
-0.29%
Technology
-1.22%
Utilities
-0.10%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
+0.55%
Please wait processing your request...